Comparison between Population Average and Experimentally Measured Arterial Input Function in Predicting Biopsy Results in Prostate Cancer

Academic Radiology

Volumn 17, Issue 4, 2010, Pages 520-525

  Meng, Ran ^a   Chang, Silvia D ^a,b   Jones, Edward C ^a   Goldenberg, S Larry ^a,b   Kozlowski, Piotr ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER PROSTATE CENTRE   (Canada)

Author keywords

arterial input function; biopsy; Dynamic contrast enhanced MRI; prostate cancer

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; INTERMETHOD COMPARISON; MALE; MEAN ARTERIAL PRESSURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL RESOLUTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ALGORITHMS; COMPUTER SIMULATION; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 77649180156     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2009.11.006     Document Type: Article

References (30)

1. Hricak H., Dooms G.C., Jeffrey R.B., et al. Prostatic carcinoma: staging by clinical assessment, CT and MR imaging. Radiology 162 (1987) 331-336
2. Barentsz J.O., Engelbrecht M., Jager G.J., et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 10 (1999) 295-304
3. Buckley D.L., Roberts C., Parker G.J., et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 233 (2004) 709-715
4. Padhani A.R., MacVicar A.D., Gapinski C.J., et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218 (2001) 265-374
5. Engelbrecht M.R., Huisman H.J., Laheij R.J., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229 (2003) 248-254
6. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 203 (1997) 645-652
7. Padhani A.R., Gapinski C.J., Macvicar D.A., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 (2000) 99-109
8. Noworolski S.M., Henry R.G., Vigneron D.B., et al. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 53 (2005) 249-255
9. Muramoto S., Uematsu H., Kimura H., et al. Differentiation of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging. Eur J Radiol 44 (2002) 52-58
10. Choyke P.L., Dwyer A.J., and Knopp M.V. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17 (2003) 509-520
11. Brawer M.K., Deering R.E., Brown M., et al. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73 (1994) 678-687
12. Bostwick D.G., Wheeler T.M., Blute M., et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 48 (1996) 47-57
13. Rijpkema M., Kaanders J.H., Joosten F.B., et al. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging 14 (2001) 457-463
14. Hawighorst H., Knapstein P.G., Weikel W., et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 57 (1997) 4777-4786
15. Hawighorst H., Knopp M.V., Debus J., et al. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results. J Magn Reson Imaging 8 (1998) 783-788
16. Evelhoch J.L. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 10 (1999) 254-259
17. Parker G.J., and Padhani A.R. T1-weighted dynamic contrast enhanced MRI. In: Tofts P.S. (Ed). Quantitative MRI of the brain-measuring changes caused by disease (2003), John Wiley and Sons Ltd, Chichester, UK 341-364
18. Tofts P.S., Berkowitz B., and Schnall M.D. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 33 (1995) 564-568
19. Parker G.J., Roberts C., Macdonald A., et al. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 56 (2006) 993-1000
20. Parker G.J., Suckling J., Tanner S.F., et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 7 (1997) 564-574
21. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
22. Kozlowski P., Chang S.D., Jones E.C., et al. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 24 (2006) 108-113
23. Mould R.F. Sensitivity and specificity. Introductory medical statistics (1998), Institute of Physics Publishing, Bristol, UK 232-233
24. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17 (2008) 857-872
25. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristics curves: a nonparametric approach. Biometrics 44 (1988) 837-845
26. Inaba T. Quantitative measurements of prostatic blood flow and blood volume by positron emission tomography. J Urol 148 (1992) 1457-1460
27. McGrath D.M., Bradley D.P., Tessier J.L., et al. Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats. Magn Reson Med 61 (2009) 1173-1184
28. Haider M.A., Chung P., Sweet J., et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 70 (2008) 425-430
29. Hara N., Okuizumi M., Koike H., et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62 (2005) 140-147
30. Langer D.L., van der Kwast T.H., Evans A.J., et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30 (2009) 327-334